Eric M. Attias

FOREPONT CAPITAL PARTNER

๐Ÿ“ New York, New York, United States๐Ÿ”„ Updated September 2026๐Ÿ’ผ 1 investments๐Ÿ“… 12 years investing๐Ÿ—“ Last invested Jul 2014
VC๐ŸŒ United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
12y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2014
A Global Alternative Investment Company
Experience ยท 4 entries
All (4)
Investments (1)
Founder (1)
Board (1)
2014
Managing Partner
Jul 2014
Forepont Capital Partners is a Medtech and biotech focused venture capital firm which was founded in 2017, headquartered in New York with a presence in Europe. Our mission is to invest in biotech, medtech and digital-health start-ups in the US and Europe while providing scientific, technological financial and operational support. The fund has developed strong and tight partnerships with industry leaders (researchers, hospitals, academia, large pharmaceutical groups) who have vastly contributed to the performance of the existing portfolio, and that contributed to generating a proprietary deal flow.
Board Member
Jul 2014
A Global Alternative Investment Company
2009
Nexar Capital
CEO Nexar Capital LLC | CIO | Co-Founder |
Apr 2009
1997
Managing Director | Global Markets | ExCo |
Mar 1997
Created in 2000 through the merger of Dresdner Kleinwort and Wasserstein Perella. The Wasserstein name was dropped in July 2006 when the investment bank was renamed back to Dresdner Kleinwort. Associate your LinkedIn profile with this Company profile for experience records ending not later than July 2006.
early stageCapital Markets